Oxford University scientists are developing a new vaccine for the rare Bundibugyo Ebola virus, potentially ready for clinical trials in 2-3 months. The outbreak in DR Congo has caused 177 deaths, with the WHO upgrading the risk to 'very high'.
Scientists at Oxford University are developing a new vaccine using ChAdOx1 technology for the rare Bundibugyo Ebola strain. Clinical trials could begin in 2-3 months, pending animal research, as the WHO upgrades the outbreak risk to 'very high' in DR Congo.
China reports a sustained recovery in wild populations of rare and endangered species, with over 200 species of wild animals and 100 species of wild plants showing signs of growth and protection.
